You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 22, June 8, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (33)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Tuberculosis/ Other Mycobacterium
 •Pulmonary Diseases
 •Pulmonary Diseases, Other
 •Radiologic Imaging
 •Radiography
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical and Radiographic Correlates of Primary and Reactivation Tuberculosis

A Molecular Epidemiology Study

Elvin Geng, MD, MPH; Barry Kreiswirth, PhD; Joe Burzynski, MD, MPH; Neil W. Schluger, MD

JAMA. 2005;293:2740-2745.

Context  The traditional teaching that pulmonary tuberculosis characterized by lymphadenopathy, effusions, and lower or mid lung zone infiltrates on chest radiography represents "primary" disease from recently acquired infection, whereas upper lobe infiltrates and cavities represent secondary or reactivation disease acquired in the more distant past, is not based on well-established clinical evidence. Furthermore, it is not known whether the atypical radiograph common in human immunodeficiency virus (HIV)–associated tuberculosis is due to a preponderance of primary progressive disease or altered immunity.

Objective  To analyze the relationship between recently acquired and remotely acquired pulmonary tuberculosis, clinical and demographic variables, and radiographic features by using molecular fingerprinting and conventional epidemiology.

Design, Setting, and Population  A retrospective, hospital-based series of 456 patients treated at a New York City medical center between 1990 and 1999. Eligible patients had to have had at least 1 positive respiratory culture for Mycobacterium tuberculosis and available radiographic data.

Main Outcome Measures  Radiographic appearance as measured by the presence or absence of 6 features: upper lobe infiltrate, cavitary lesion, adenopathy, effusions, lower or mid lung zone infiltrate, and miliary pattern. Radiographs were considered typical if they had an upper lobe infiltrate or cavity whether or not other features were present. Atypical radiographs were those that had adenopathy, effusion, or mid lower lung zone infiltrates or had none of the above features.

Results  Human immunodeficiency virus infection was most commonly associated with an atypical radiographic appearance on chest radiograph with an odds ratio of 0.20 (95% confidence interval, 0.13-0.31). Although a clustered fingerprint, representing recently acquired disease, was associated with typical radiograph in univariate analysis (odds ratio, 0.68; 95% confidence interval, 0.47-0.99), the association was lost when adjusted for HIV status.

Conclusions  Time from acquisition of infection to development of clinical disease does not reliably predict the radiographic appearance of tuberculosis. Human immunodeficiency virus status, a probable surrogate for the integrity of the host immune response, is the only independent predictor of radiographic appearance. The altered radiographic appearance of pulmonary tuberculosis in HIV is due to altered immunity rather than recent acquisition of infection and progression to active disease.


Author Affiliations: College of Physicians and Surgeons (Drs Geng and Schluger) and Mailman School of Public Health (Dr Schluger), Columbia University, New York, NY; Public Health Research Institute, Newark, NJ (Dr Kreiswirth); and New York City Department of Health Tuberculosis Control Program, New York (Dr Burzynski).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis of Active Tuberculosis in China Using an In-House Gamma Interferon Enzyme-Linked Immunospot Assay
Chen et al.
CVI 2009;16:879-884.
ABSTRACT | FULL TEXT  

Reply
Jeong et al.
Am. J. Roentgenol. 2009;192:W199-W200.
FULL TEXT  

Pulmonary Tuberculosis: Up-to-Date Imaging and Management
Jeong and Lee
Am. J. Roentgenol. 2008;191:834-844.
ABSTRACT | FULL TEXT  

Detailed Analysis of the Radiographic Presentation of Mycobacterium kansasii Lung Disease in Patients With HIV Infection
Cattamanchi et al.
Chest 2008;133:875-880.
ABSTRACT | FULL TEXT  

Quantitative Impact of Human Immunodeficiency Virus Infection on Tuberculosis Dynamics
DeRiemer et al.
Am. J. Respir. Crit. Care Med. 2007;176:936-944.
ABSTRACT | FULL TEXT  

33-Year-Old Man With Cough, Fever, and Weight Loss
Burnette and Beckman
Mayo Clin Proc. 2007;82:1265-1268.
FULL TEXT  

What's Driving the Decline in Tuberculosis in Arkansas? A Molecular Epidemiologic Analysis of Tuberculosis Trends in a Rural, Low-Incidence Population, 1997 2003
France et al.
Am J Epidemiol 2007;166:662-671.
ABSTRACT | FULL TEXT  

Radiographic Appearance of Primary Tuberculosis
Leey and McKinney
ANN INTERN MED 2007;146:395-395.
FULL TEXT  

Update in infectious diseases.
Lorber
ANN INTERN MED 2006;145:354-360.
FULL TEXT  

The Prevalence of Pulmonary Parenchymal Tuberculosis in Patients With Tuberculous Pleuritis
Kim et al.
Chest 2006;129:1253-1258.
ABSTRACT | FULL TEXT  

Molecular Typing Sheds New Light on Radiographic Presentation of TB
JWatch Infect. Diseases 2005;2005:7-7.
FULL TEXT  

Radiographic Correlates of Pulmonary TB: Not What We Were Taught
JWatch General 2005;2005:3-3.
FULL TEXT  

Tuberculosis--A Global Problem Requiring a Global Solution
DeAngelis and Flanagin
JAMA 2005;293:2793-2794.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.